Conference Coverage: SABCS 2021 – Focus on Breast Cancer

Expert perspectives and strategic insights on the latest therapeutic developments in breast cancer treatment.

December 14, 2021


Adam Brufsky, MD, PhD

UPMC Hillman Cancer Center, Pittsburgh, PA, USA

Faculty Members

Miguel Martin, MD, PhD
Complutense University, Madrid, Spain

Javier Cortes, MD, PhD
Vall d’Hebron University Hospital, Barcelona, Spain

Joyce A. O’Shaughnessy, MD
Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA

Mark Pegram, MD
Stanford Cancer Institute, CA, USA

Hope Rugo, MD, FASCO
UCSF Helen Diller Family Comprehensive Cancer Center, CA, USA

Mary Cianfrocca, DO, MBA
City of Hope, Duarte, CA, USA

Sample Report

Start discovering the insights

View Report


The report was based on the following topics

  • Advancing Therapy for Metastatic HER2+ Breast Cancer
  • Other Novel Endocrine Strategies for ER+ Breast Cancer
  • ER+ Breast Cancer – Targeting CDKs
  • Targeting Triple-Negative Breast Cancer
  • Biomarkers and Tailored Therapy
  • Other Novel Therapeutic Approaches for Breast Cancer

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.